Literature DB >> 1934187

Effect of molecular weight in amphipathic polyethyleneglycol on prolonging the circulation time of large unilamellar liposomes.

K Maruyama1, T Yuda, A Okamoto, C Ishikura, S Kojima, M Iwatsuru.   

Abstract

The effect in mice of the molecular weight of polyethyleneglycol on prolonging the circulation time of large unilamellar liposomes (LUVs) was examined using four different distearoyl N-(monomethoxy polyethyleneglycol succinyl) phosphatidylethanolamines (DSPE-PEGs). The molecular weights tested were 1000, 2000, 5000 and 12000. Incorporation of 6 mol% of DSPE-PEG in LUV composed of distearoylphosphatidylcholine (DSPC) / cholesterol (CH) (1:1 in molar ratio) increased the blood circulation half-life significantly more than those without DSPE-PEG derivatives. DSPE-PEGs with molecular weights of 1000 and 2000 prolonged the circulation time of liposomes more than other DSPE-PEGs with higher molecular weights, such as 5000 and 12000. Their effects are also higher than ganglioside GM1, a well described glycolipid with this effect. DSPC/CH LUV-incorporated DSPE-PEG with a molecular weight of 2000 displayed a high concentration in the blood, approximately 40% of the dose, 6 h after the injection.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1934187     DOI: 10.1248/cpb.39.1620

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  19 in total

1.  The effect of chain length on protein solubilization in polymer-based vesicles (polymersomes).

Authors:  Veena Pata; Nily Dan
Journal:  Biophys J       Date:  2003-10       Impact factor: 4.033

2.  Encapsulation and release of Amphotericin B from an ABC triblock fluorous copolymer.

Authors:  Jun-Pil Jee; Aaron McCoy; Sandro Mecozzi
Journal:  Pharm Res       Date:  2011-07-08       Impact factor: 4.200

3.  Optimization of PEGylation conditions for BSA nanoparticles using response surface methodology.

Authors:  Hasan Kouchakzadeh; Seyed Abbas Shojaosadati; Amir Maghsoudi; Ebrahim Vasheghani Farahani
Journal:  AAPS PharmSciTech       Date:  2010-08-03       Impact factor: 3.246

4.  Effects of polyethyleneglycol chain length and phospholipid acyl chain composition on the interaction of polyethyleneglycol-phospholipid conjugates with phospholipid: implications in liposomal drug delivery.

Authors:  F K Bedu-Addo; P Tang; Y Xu; L Huang
Journal:  Pharm Res       Date:  1996-05       Impact factor: 4.200

5.  Interaction of polyethyleneglycol-phospholipid conjugates with cholesterol-phosphatidylcholine mixtures: sterically stabilized liposome formulations.

Authors:  F K Bedu-Addo; P Tang; Y Xu; L Huang
Journal:  Pharm Res       Date:  1996-05       Impact factor: 4.200

6.  Effects on interactions of oppositely charged phospholipid vesicles of covalent attachment of polyethylene glycol oligomers to their surfaces: adhesion, hemifusion, full fusion and "endocytosis".

Authors:  Guohua Lei; Robert C MacDonald
Journal:  J Membr Biol       Date:  2008-01-18       Impact factor: 1.843

7.  Enhanced delivery and antitumor activity of doxorubicin using long-circulating thermosensitive liposomes containing amphipathic polyethylene glycol in combination with local hyperthermia.

Authors:  S Unezaki; K Maruyama; N Takahashi; M Koyama; T Yuda; A Suginaka; M Iwatsuru
Journal:  Pharm Res       Date:  1994-08       Impact factor: 4.200

8.  Polystyrene-poly (ethylene glycol) (PS-PEG2000) particles as model systems for site specific drug delivery. 2. The effect of PEG surface density on the in vitro cell interaction and in vivo biodistribution.

Authors:  S E Dunn; A Brindley; S S Davis; M C Davies; L Illum
Journal:  Pharm Res       Date:  1994-07       Impact factor: 4.200

Review 9.  Targeted pharmaceutical nanocarriers for cancer therapy and imaging.

Authors:  Vladimir P Torchilin
Journal:  AAPS J       Date:  2007-05-11       Impact factor: 4.009

Review 10.  Multifunctional and stimuli-sensitive pharmaceutical nanocarriers.

Authors:  Vladimir Torchilin
Journal:  Eur J Pharm Biopharm       Date:  2008-10-17       Impact factor: 5.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.